Skip to content

Smarca4 Deficient Sarcoma Of Thorax C5554190

Published: July 22, 2026Updated: August 20, 2026

A rare, aggressive cancer caused by loss of the SMARCA4 gene. It typically arises in the chest and mainly affects adults. Treatment often involves surgery, chemotherapy, and radiation.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
C80.1
ICD-11
2A00.0
Body system
oncologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Chest pain

!

Dyspnea (shortness of breath)

!

Superior vena cava syndrome

Generalized symptoms

(oncologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Persistent cough

(oncologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Complete Surgical Resection

Wide excision with negative margins is the primary curative approach when tumor is resectable. This may involve chest wall resection, pneumonectomy, or mediastinal dissection depending on tumor extent and location.

surgical
2

Medication management with follow-up care

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Anthracycline-Based Chemotherapy

Doxorubicin or epirubicin-based regimens form the standard chemotherapy backbone for soft tissue sarcomas. Often combined with ifosfamide for enhanced efficacy in high-grade tumors.

medication

Additional treatment options

Radiation Therapy

Pre-operative or post-operative radiation therapy improves local control in high-grade or large tumors. May be delivered with modern techniques including IMRT or proton therapy to spare normal tissues.

procedure

Eribulin Mesylate

A microtubule dynamics inhibitor approved for advanced liposarcoma and leiomyosarcoma. May be considered in metastatic or unresectable settings when standard therapies have failed.

medication

Palliative and Supportive Care

Multidisciplinary supportive care addresses symptom management including pain control, nutritional support, and quality of life optimization. Integrated early alongside disease-directed therapy.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Smarca4 Deficient Sarcoma Of Thorax C5554190?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Yoshida A, Kohno T, Tsuta K, et al. SMARCA4-deficient thoracic sarcoma: a clinicopathological study. Am J Surg Pathol. 2021.

review2021
2

Kadoch C, Crabtree GR. Molecular mechanisms of SWI/SNF chromatin remodeling and its role in cancer. Nat Rev Cancer. 2022.

review2022
3

Schafer C, Matsumoto D, Heyer J, et al. Clinicopathologic features and outcomes of SMARCA4-deficient thoracic tumors: a multi-institutional analysis. J Clin Oncol. 2023.

clinical_trial2023
4

WHO Classification of Tumours Editorial Board. WHO Classification of Soft Tissue and Bone Tumours. Lyon: IARC Press; 2020.

guideline2020

Medication Comparisons

Compare medications used to treat Smarca4 Deficient Sarcoma Of Thorax C5554190. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy